Invech Holdings, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Invech Holdings, Inc. files an amended 10-Q for the period ending June 30, 2026, primarily to correct financial statements, while disclosing ongoing operational losses and material weaknesses in internal controls.
OTC.Pink
Invech Holdings, Inc. filed its Q2 2026 report, revealing no revenue, a substantial net loss of $202,739 for the six months ended June 30, 2026, and significant concerns about its ability to continue as a going concern.
OTC.Pink
Invech Holdings, Inc. filed its Q1 2026 Form 10-Q, detailing a strategic shift towards SaaS software development and corporate filings, alongside a significant acquisition.
OTC.Pink
Invech Holdings, Inc. reported a net loss of $9,077 for the third quarter of 2025 and an accumulated deficit of $355,022, continuing to operate without revenue.
OTC.Pink
Invech Holdings, Inc. reported a net loss of $7,503 for Q2 2025 with no revenue, continuing to raise substantial doubt about its ability to operate as a going concern and highlighting material weaknesses in internal controls.
OTC.Pink
10-Q: Invech Holdings Reports Q1 2025 Results: No Revenue, Continued Losses, and Going Concern Uncertainty
Invech Holdings, Inc. reports no revenue and a net loss of $31,377 for the three months ended March 31, 2025, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
Invech Holdings, now focused on regulatory compliance consulting, reports a net loss of $51,423 for the nine months ended September 30, 2024, with no revenue generated.
OTC.Pink
Invech Holdings, Inc. reports increased operating expenses and a widened net loss for the quarter ended June 30, 2024, as the company focuses on regulatory compliance consulting.